dc.contributor.author |
Elkıran, Özlem |
|
dc.contributor.author |
Karakurt, Cemşit |
|
dc.contributor.author |
Koçak, Gülemdar |
|
dc.contributor.author |
Tabel, Yılmaz |
|
dc.contributor.author |
Güngör, Serdal |
|
dc.date.accessioned |
2018-01-18T11:10:02Z |
|
dc.date.available |
2018-01-18T11:10:02Z |
|
dc.date.issued |
2015 |
|
dc.identifier.citation |
Ö. Elkıran, C. Karakurt, G. Koçak, Y. Tabel, And S. Güngör, “Possible Association Between Fluconazole Administration And Acute Hyperkalemia İn A Critically İll Cyanotic İnfant ,” Arch Med Sci, Vol. 11, No. 1, Pp. 235–6, 2015. |
tr_TR |
dc.identifier.uri |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4379377/pdf/AMS-11-24661.pdf |
|
dc.identifier.uri |
http://hdl.handle.net/11616/7998 |
|
dc.description |
Arch Med Sci 2015; 11, 1: 235–236 |
tr_TR |
dc.description.abstract |
Fluconazole, an azole antifungal agent, inhibits the fungal cytochrome
P450 enzyme. Although in vitro data show that fluconazole is not a potent
inhibitor of mammalian P450 enzymes, hyperkalemia secondary to
adrenal insufficiency associated with fluconazole has been described
rarely [1–3]. However, life-threatening severe hyperkalemia related to administration
of intravenous fluconazole without adrenal suppression has
not been reported before. |
tr_TR |
dc.language.iso |
eng |
tr_TR |
dc.publisher |
Arch Med Sci |
tr_TR |
dc.rights |
info:eu-repo/semantics/openAccess |
tr_TR |
dc.title |
Possible association between fluconazole administration and acute hyperkalemia in a critically ill cyanotic infant |
tr_TR |
dc.type |
article |
tr_TR |
dc.relation.journal |
Arch Med Sci |
tr_TR |
dc.contributor.department |
İnönü Üniversitesi |
tr_TR |
dc.contributor.authorID |
113476 |
tr_TR |
dc.contributor.authorID |
113274 |
tr_TR |
dc.contributor.authorID |
31161 |
tr_TR |
dc.contributor.authorID |
102525 |
tr_TR |
dc.identifier.volume |
11 |
tr_TR |
dc.identifier.issue |
1 |
tr_TR |
dc.identifier.startpage |
235 |
tr_TR |
dc.identifier.endpage |
236 |
tr_TR |